AKERO THERAPEUTICS INC (AKRO) Stock Cash Flow
USA - NASDAQ:AKRO - US00973Y1082 - Common Stock
53.88 USD
-0.2 (-0.37%)
53.88 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -283.96M | -252.06M | -151.76M | -112.03M | -100.78M | |||
| Depreciation Amortization | 18.00K | 18.00K | 29.00K | 40.00K | 40.00K | |||
| Change In Working Capital | 8.88M | 3.00M | -6.67M | -4.46M | 9.73M | |||
| Interest Paid | 4.10M | 3.98M | 2.48M | 440.00K | N/A | |||
| Other non cash items | 21.18M | 18.94M | 13.03M | 23.93M | 11.33M | |||
| OPERATING CASH FLOW | -253.02M | -230.11M | -145.37M | -92.52M | -79.68M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -999.00K | N/A | N/A | 0.00 | |||
| Other Investing Activity | -314.55M | -108.71M | -223.62M | -63.83M | 42.28M | |||
| INVESTING CASH FLOW | -314.55M | -109.71M | -223.62M | -63.83M | 42.28M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 10.00M | 15.00M | 9.61M | N/A | |||
| Stock Issued/Repurchased | 478.23M | 436.69M | 339.09M | 246.50M | 1.12M | |||
| Other Financing Activity | -670.00K | -844.00K | -776.00K | -470.00K | -520.00K | |||
| FINANCING CASH FLOW | 477.81M | 445.85M | 353.32M | 255.63M | 600.00K | |||
| CHANGE IN CASH | -89.76M | 106.03M | -15.67M | 99.28M | -36.80M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -253.02M | -230.11M | -145.37M | -92.52M | -79.68M | |||
| Capital Expenditure | N/A | -999.00K | N/A | N/A | 0.00 | |||
| FREE CASH FLOW | -253.02M | -231.11M | -145.37M | -92.52M | -79.68M | |||
All data in USD